CD8A and neoplasm: High-risk patients exhibited elevated CD8+ T cell proportions but reduced naïve CD4+ T cells and γδ T cells.[40] These insights advocate for early intervention strategies to enhance neutrophil/NK cell cytotoxicity, tumor antigen presentation, and CD8+ T cell polyfunctionality, thereby reprogramming the immunosuppressive TME to disrupt tumor proliferation and improve therapeutic outcomes.